InvestorsHub Logo
Followers 48
Posts 1181
Boards Moderated 0
Alias Born 04/20/2018

Re: None

Wednesday, 05/23/2018 11:50:30 PM

Wednesday, May 23, 2018 11:50:30 PM

Post# of 111073
Gisano - Excellent idea and initiative on your part. You may want to send a quick email to CELZ leadership to give them a heads up that you've reached out to the Newsweek author. I can't foresee them turning down an opportunity to speak with Newsweek about CaverStem. Especially as CMTH is now in commercialization and there are no FDA issues associated with the procedure as discussed many times on this board.

Everyday I am more impressed with CMTH/CELZ leadership team. They are buttoned-up professionals who appear to have a strong grasp of what they want to accomplish and how to make it reality. They don't over promise and under deliver. Out of the companies I've researched in the OTC, this CMTH/CELZ operates most like a big board company. I'm sure they plan to uplist in the future which will be beneficial on many fronts, unless they are acquired first. This is a stock to hold because unless something derails their march forward, a year from now the share price will look completely different than today. And that will benefit all of us.

Good thinking on your part and excellent initiative!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CELZ News